Caffo, Orazio

Caffo, Orazio  

CIBIO (29/10/12-)  

Mostra records
Risultati 1 - 20 di 114 (tempo di esecuzione: 0.028 secondi).
Titolo Anno di pubblicazione Autori Unitn File
1730P Electronic medical record (EMR)-assisted phone follow-up (PFU) for breast cancer survivors (CS) during COVID-19 pandemic: An Italian single institution experience 1-gen-2020 Piras, Enrico MariaZanutto, AlbertoCaffo, Orazio +
A model-based framework to identify optimal administration protocols for immunotherapies in castration-resistance prostate cancer 1-gen-2022 Coletti R.Pugliese A.Lunardi A.Caffo O.Marchetti L.
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study) 1-gen-2024 Caffo, Orazio +
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study 1-gen-2004 Caffo O +
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial 1-gen-2022 Caffo O +
A report of progressive multifocal leukoencephalopathy during adjuvant abemaciclib for breast cancer 1-gen-2026 Caffo O. +
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer 1-gen-2019 Caffo O +
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer 1-gen-2010 Caffo O +
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network 1-gen-2022 Caffo O +
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study 1-gen-2025 Caffo, Orazio +
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review 1-gen-2022 Caffo O +
Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer. 1-gen-2016 Caffo O +
Association of G8 screening tool with prognosis and survival in patients with non-small cell lung cancer: A retrospective analysis from a single institution 1-gen-2025 Veccia, AntonelloPontalti, StefanoCaffo, Orazio +
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR-positive non small cell lung cancer patients: Results from a multicenter Italian observational study. 1-gen-2016 Caffo O +
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 1-gen-2024 Caffo O. +
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 1-gen-2020 Caffo, Orazio +
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA. 1-gen-2017 Caffo O +
Cardiovascular toxicities of systemic treatments of prostate cancer 1-gen-2017 Caffo O +
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study 1-gen-2024 Caffo, Orazio +
Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A Multidisciplinary Consensus Project of the Italian Society for Uro-Oncology (SIUrO) 1-gen-2025 Caffo, Orazio +